EDAP
Edap Tms S.a.
NASDAQ · Healthcare · Medical - Devices · FR
$4.76
−0.52%Income statement
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue | |||||
| Total Revenue | 72.0M | 70.7M | 64.1M | 60.4M | 55.1M |
| Cost of Revenue | 40.7M | 40.7M | 37.6M | 36.0M | 30.9M |
| Gross Profit | 31.3M | 30.1M | 26.6M | 24.4M | 24.2M |
| Operating Expenses | |||||
| R&D Expense | 9.4M | 8.6M | 7.7M | 7.0M | 4.9M |
| SG&A Expense | 22.2M | 45.0M | 39.4M | 37.3M | 23.5M |
| General & Admin Expense | 5.8M | 17.7M | 14.1M | 14.6M | 7.2M |
| Selling & Marketing Expense | (7.1M) | 27.3M | 25.3M | 22.6M | 16.4M |
| Other Expenses | 24.7M | 1.7M | — | 1.0K | — |
| Total Operating Expenses | 56.2M | 55.3M | 47.1M | 44.2M | 28.4M |
| Cost and Expenses | 96.9M | 96.0M | 84.6M | 80.2M | 59.4M |
| Operating Income (EBIT) | (24.9M) | (25.2M) | (20.5M) | (19.8M) | (4.3M) |
| Non-Operating | |||||
| Interest Income | — | 252.8K | 796.0K | 1.3M | 404.0K |
| Interest Expense | 4.8M | 791.4K | 236.0K | 232.0K | 168.0K |
| Net Interest Income | (4.8M) | (538.7K) | 560.0K | 1.1M | 236.0K |
| Other Non-Op Income/Expense | (4.7M) | (4.1M) | 1.8M | (720.0K) | 2.2M |
| Non-Operating Income (excl Interest) | 144.4K | 3.3M | (2.0M) | 488.0K | (2.3M) |
| EBT (Pre-Tax Income) | (29.6M) | (29.3M) | (18.7M) | (20.5M) | (2.1M) |
| Income Tax Expense | 423.8K | 71.2K | 289.0K | 644.0K | 837.0K |
| Bottom Line | |||||
| Net Income | (30.0M) | (29.3M) | (19.0M) | (21.2M) | (2.9M) |
| Earnings from Cont. Ops | (30.0M) | (29.3M) | (19.0M) | (21.2M) | (2.9M) |
| Earnings from Discont. Ops | — | — | — | — | — |
| Bottom Line Net Income | (30.0M) | (29.3M) | (19.0M) | (21.2M) | (2.9M) |
| Per Share | |||||
| Basic EPS | ($0.77) | ($0.78) | ($0.51) | ($0.57) | ($0.09) |
| Diluted EPS | ($0.77) | ($0.78) | ($0.51) | ($0.57) | ($0.09) |
| Revenue Per Share | $1.92 | $1.89 | $1.72 | $1.63 | $1.60 |
| Shares | |||||
| Basic Shares Outstanding | 37.5M | 37.4M | 37.3M | 37.0M | 34.4M |
| Diluted Shares Outstanding | 37.5M | 37.4M | 37.3M | 37.0M | 34.4M |
| Profitability Metrics | |||||
| EBITDA | (23.5M) | (25.0M) | (15.9M) | (18.4M) | (319.5K) |
| D&A | 1.5M | 3.4M | 2.6M | 1.9M | 1.6M |
| EBIT | (25.1M) | (28.5M) | (18.5M) | (20.3M) | (1.9M) |
As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Mar 1, 2026